An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Name: An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting
Published: 2024
License: Public Domain

Regeneron Pharmaceuticals · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

visual-impairment

neovascular age-related macular degeneration (namd), wet age-related macular degeneration (amd), diabetic macular edema (dme), visual impairment, treatment-naïve, previously treated, degenerative disease, vascular endothelial growth factor (vegf), diabetic retinopathy (dr), observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Related documents